Potent and Selective Non-Cysteine-Containing Inhibitors of Protein Farnesyltransferase

David J. Augeri, Stephen J. O’Connor, Dave Janowick, Bruce G. Szczepankiewicz, Gerry Sullivan, John J. Larsen, Douglas Kalvin, Jerry D. Cohen, Edward M. Devine, Haichao Zhang,

Journal of Medicinal Chemistry · 1998 · 43 citations · 16 references

DOIFull text

Open access

Concepts

Abstract

Potent and selective non-thiol-containing inhibitors of protein farnesyltransferase are described. FTI-276 (1) was transformed into pyridyl ether analogue 19. The potency of pyridyl ether 19 was improved by modification of the biphenyl core to that of an o-tolyl substituted biphenyl core to give 29. In addition to 0.4 nM in vitro potency, 29 displayed 350 nM potency in whole cells as the parent carboxylic acid. The o-tolyl biphenyl core dramatically and unexpectedly enhanced the potency of other compounds as exemplified by 46, 47, 48, and 49.

References

16